ATE507309T1 - Verfahren zur erkennung eines oralen plattenepithelkarzinoms und mittel zu dessen unterdrückung - Google Patents

Verfahren zur erkennung eines oralen plattenepithelkarzinoms und mittel zu dessen unterdrückung

Info

Publication number
ATE507309T1
ATE507309T1 AT09151217T AT09151217T ATE507309T1 AT E507309 T1 ATE507309 T1 AT E507309T1 AT 09151217 T AT09151217 T AT 09151217T AT 09151217 T AT09151217 T AT 09151217T AT E507309 T1 ATE507309 T1 AT E507309T1
Authority
AT
Austria
Prior art keywords
cell carcinoma
oral squamous
suppressing
carcinoma
detecting
Prior art date
Application number
AT09151217T
Other languages
English (en)
Inventor
Johji Inazawa
Ken-Ichi Kozaki
Issei Imoto
Original Assignee
Fujifilm Corp
Nat Univ Corp Tokyo Med & Dent
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujifilm Corp, Nat Univ Corp Tokyo Med & Dent filed Critical Fujifilm Corp
Application granted granted Critical
Publication of ATE507309T1 publication Critical patent/ATE507309T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/154—Methylation markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/16—Primer sets for multiplex assays
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/178—Oligonucleotides characterized by their use miRNA, siRNA or ncRNA
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/142222—Hetero-O [e.g., ascorbic acid, etc.]
    • Y10T436/143333—Saccharide [e.g., DNA, etc.]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT09151217T 2008-01-23 2009-01-23 Verfahren zur erkennung eines oralen plattenepithelkarzinoms und mittel zu dessen unterdrückung ATE507309T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2008012256A JP5116026B2 (ja) 2008-01-23 2008-01-23 癌の検出方法および癌抑制剤

Publications (1)

Publication Number Publication Date
ATE507309T1 true ATE507309T1 (de) 2011-05-15

Family

ID=40748687

Family Applications (1)

Application Number Title Priority Date Filing Date
AT09151217T ATE507309T1 (de) 2008-01-23 2009-01-23 Verfahren zur erkennung eines oralen plattenepithelkarzinoms und mittel zu dessen unterdrückung

Country Status (5)

Country Link
US (2) US20090202624A1 (de)
EP (1) EP2088208B1 (de)
JP (1) JP5116026B2 (de)
AT (1) ATE507309T1 (de)
DE (1) DE602009001116D1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5567555B2 (ja) * 2009-04-16 2014-08-06 学校法人慶應義塾 頭頸部腫瘍増殖抑制剤
EP2283846A1 (de) 2009-08-12 2011-02-16 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. miRNA-Verbindungen zur Behandlung von Prostatakarzinomen
JP5812491B2 (ja) * 2009-10-01 2015-11-11 国立研究開発法人国立がん研究センター 腫瘍治療剤
WO2011067346A1 (en) * 2009-12-04 2011-06-09 Institut National De La Sante Et De La Recherche Medicale (Inserm) Method for determining the efficiency of a cancer treatment
EP2594275B1 (de) 2010-07-08 2016-05-11 Takeda Pharmaceutical Company Limited Prophylaktischer oder therapeutischer wirkstoff gegen diabetes
US20130237456A1 (en) * 2011-05-06 2013-09-12 Jia Fan Marker consisting of plasma microrna and a new method for diagnosis of hepatocellular carcinoma
JPWO2013038737A1 (ja) 2011-09-16 2015-03-23 Lsipファンド運営合同会社 膀胱癌細胞の検出方法、膀胱癌細胞の検出方法に用いるプライマー及び膀胱癌マーカ
WO2013071502A1 (en) * 2011-11-17 2013-05-23 Genedia Biotech Co Ltd Mir-193a-3p and associated genes predict tumorigenesis and chemotherapy outcomes
EP3369818B1 (de) * 2011-12-22 2021-06-09 InteRNA Technologies B.V. Mirna zur behandlung von kopf-hals-karzinom
EP2963125B1 (de) * 2013-02-15 2020-09-30 National University Corporation Tokyo Medical and Dental University Therapeutisches mittel zur behandlung eines krebses, in dem nrf2 stabilisiert ist
WO2017079571A1 (en) * 2015-11-05 2017-05-11 Arphion Diagnostics Process for the indentication of patients at risk for oscc
KR20240158357A (ko) * 2017-11-09 2024-11-04 가부시키가이샤 팜엑스 테라퓨틱스 miRNA를 포함하는 암 치료용 의약 조성물
US20210071259A1 (en) * 2017-12-13 2021-03-11 Hiroshima University Method for assisting detection of head and neck cancer
WO2020245822A1 (en) * 2019-06-03 2020-12-10 Carmel Haifa University Economic Corporation Ltd. Human head and neck cancer treatment
TWI917330B (zh) 2019-08-09 2026-03-11 日商Ube股份有限公司 胞外體的產生方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1713938A2 (de) 2004-02-09 2006-10-25 Thomas Jefferson University Diagnose und behandlung von krebserkrankungen mit oder nahe mit krebs in zusammenhang stehenden chromosomalen merkmalen lokalisierter microrna
ES2534300T3 (es) 2004-11-12 2015-04-21 Asuragen, Inc. Procedimientos y composiciones que implican miARN y moléculas inhibidoras de miARN
AU2007205234B2 (en) * 2006-01-05 2012-07-12 The Ohio State University Research Foundation MicroRNA-based methods and compositions for the diagnosis, prognosis and treatment of lung cancer
EP2484782B1 (de) * 2006-01-05 2015-11-18 The Ohio State University Research Foundation Verfahren und Zusammensetzungen auf Mikro-RNA-Basis zur Diagnose und Behandlung von soliden Krebs
WO2007126150A1 (ja) * 2006-04-27 2007-11-08 National University Corporation Nagoya University 癌の新規治療用組成物
ES2425387T3 (es) * 2006-07-13 2013-10-15 The Ohio State University Research Foundation Mir-106a para diagnosticar adenocarcinoma de colon de pronóstico de supervivencia pobre

Also Published As

Publication number Publication date
US20110076768A1 (en) 2011-03-31
JP5116026B2 (ja) 2013-01-09
EP2088208B1 (de) 2011-04-27
US8183223B2 (en) 2012-05-22
JP2009171876A (ja) 2009-08-06
US20090202624A1 (en) 2009-08-13
DE602009001116D1 (de) 2011-06-09
EP2088208A1 (de) 2009-08-12

Similar Documents

Publication Publication Date Title
DE602009001116D1 (de) Verfahren zur Erkennung eines oralen Plattenepithelkarzinoms und Mittel zu dessen Unterdrückung
ATE522627T1 (de) Verfahren zur herstellung von nukleinsäuresonden
DE602007002090D1 (de) Verfahren zur Erkennung von anaplastischem Schilddrüsenkrebs, und Verfahren zur seiner Unterdrückung
EP3862439A3 (de) Leberkrebsdetektionskit oder -vorrichtung und detektionsverfahren
EP4461824A3 (de) Kit oder vorrichtung zur erkennung von gallengangkrebs und nachweisverfahren
EP2262911A4 (de) Zusammensetzungen, verfahren und kits mit synthetischen sonden zum nachweis der anwesenheit einer target-nukleinsäure
DK3581662T3 (da) Sammensætninger og fremgangsmåder til detektering og identificering af nukleinsyresekvenser i biologiske prøver
WO2011055916A3 (ko) 장암 진단을 위한 장암 특이적 메틸화 마커 유전자의 메틸화 검출방법
WO2011141908A3 (en) Fluids testing apparatus and methods of use
EP2402423A4 (de) An monoterpenbestandteilen reiches ätherisches öl, verfahren zu seiner herstellung und verfahren zur sanierung von umweltschadstoffen anhand des ätherischen öls
EP2547809A4 (de) Verfahren, sondensets und kits zur erkennung der zerstörung von tumorunterdrückergenen durch in-situ-fluoreszenz-hybridisierung
WO2008054556A3 (en) Methods and compositions for detection of a target nucleic acid sequence
WO2013106844A3 (en) Methods and compositions for the treatment and diaginosis of pancreatic cancer
WO2013102108A3 (en) Nucleic acid hybridization probes
DE602008006254D1 (de) Doppel-oligonukleotid-nukleinsäurenachweisverfahren
EP2518158A4 (de) Marker für pankreaskarzinom, nachweisverfahren, kits und biochips dafür
ATE533838T1 (de) Verfahren zur verbesserten einführung von dna in bakterienzellen
WO2009149319A3 (en) Gene expression profiles associated with asthma exacerbation attacks
MY160850A (en) Polymer-bonded perylene dyes and compositions containing same
AT10182U3 (de) Verfahren zur überwachung von leistungsprüfständen, sowie leistungsprüfstand
PH12017500798A1 (en) Pna probes, kits and methods for detecting human papillomavirus genotypes of human papillomavirus
MX363880B (es) Sondas, cebadores cooperativos y aplicaciones de ellos.
WO2019094780A3 (en) Non-coding rna for detection of cancer
EP2504348A4 (de) Verfahren, reagenzien und kits für den nachweis von nukleinsäuremolekülen
ATE544070T1 (de) Verfahren zum nachweis von tumorspezifischen fusionsproteinen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties